Status:
COMPLETED
Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rotavirus
Gastroenteritis
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to evaluate whether V260 is effective and well tolerated in Japanese healthy infants.
Eligibility Criteria
Inclusion
- Healthy Japanese Infants, 6 Weeks Through 12 Weeks Of Age
Exclusion
- History Of Known Prior Rotavirus Gastroenteritis
- Subjects Who Are Concurrently Participating In Or Are Anticipated To Participate In Other Studies Of Investigational Products At Any Time During The Study Period
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
762 Patients enrolled
Trial Details
Trial ID
NCT00718237
Start Date
August 1 2008
End Date
August 1 2009
Last Update
April 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.